drug · small molecule
GLK-302
Phase 2updated 3mo agoby $GKOS GLAUKOS Corp🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 4 investigational indications.
targets
Muscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M3
all catalysts(0)
nothing on the calendar yet
Trials studying GLK-302
- phase3Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia
- phase2Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia
- EP1Evaluation of NV701 (Pilocarpine 1.25%) Compared With Vuity (Pilocarpine 1.25%) on Pupil Size in Subjects With Presbyopia
- phase3Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia
- phase4Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)
- phase3Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults
- phase2Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia
- phase2Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that